Industry: Chemical & Material
Published Date: 2025-02-22
Pages: 108 Pages
Report ld: 4183080
Request Sample
Customized Report
Scopolamine Butyl Bromide API Market Size(US$)

CAGR 2025-2031
4.4%
Market Size,2031
USD 1,708
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Scopolamine Butyl Bromide API was valued at US$ 1265 million in the year 2024 and is projected to reach a revised size of US$ 1708 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Scopolamine Butyl Bromide API (also known as Hyoscine Butylbromide API) is the active pharmaceutical ingredient (API) used in the formulation of medications for gastrointestinal and smooth muscle disorders. It is a quaternary ammonium derivative of scopolamine (hyoscine) and acts as an anticholinergic and antispasmodic agent.
North American market for Scopolamine Butyl Bromide API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Scopolamine Butyl Bromide API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Scopolamine Butyl Bromide API include Boehringer Ingelheim, Alkaloids Corporation, Alchem International Private Ltd, Abbott Laboratories, Sanofi, LGM Pharma, Transo-Pharm Handels GmbH, Aspen API, Jai Radhe Sales, Tenatra Chemie, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Scopolamine Butyl Bromide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scopolamine Butyl Bromide API.
The Scopolamine Butyl Bromide API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Scopolamine Butyl Bromide API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Scopolamine Butyl Bromide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Scopolamine Butyl Bromide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Scopolamine Butyl Bromide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Scopolamine Butyl Bromide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Scopolamine Butyl Bromide API Market Overview
1.1 Product Definition
1.2 Scopolamine Butyl Bromide API by Type
1.2.1 Global Scopolamine Butyl Bromide API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Pharmaceutical Grade
1.2.3 Industrial Grade
1.3 Scopolamine Butyl Bromide API by Application
1.3.1 Global Scopolamine Butyl Bromide API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Urinary Tract Spasm
1.3.3 Biliary Tract Spasm
1.3.4 Gastrointestinal Spasm
1.4 Global Market Growth Prospects
1.4.1 Global Scopolamine Butyl Bromide API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Scopolamine Butyl Bromide API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Scopolamine Butyl Bromide API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Scopolamine Butyl Bromide API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Scopolamine Butyl Bromide API Production Market Share by Manufacturers (2020-2025)
2.2 Global Scopolamine Butyl Bromide API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Scopolamine Butyl Bromide API, Industry Ranking, 2023 VS 2024
2.4 Global Scopolamine Butyl Bromide API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Scopolamine Butyl Bromide API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Scopolamine Butyl Bromide API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Scopolamine Butyl Bromide API, Product Offered and Application
2.8 Global Key Manufacturers of Scopolamine Butyl Bromide API, Date of Enter into This Industry
2.9 Scopolamine Butyl Bromide API Market Competitive Situation and Trends
2.9.1 Scopolamine Butyl Bromide API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Scopolamine Butyl Bromide API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Scopolamine Butyl Bromide API Production by Region
3.1 Global Scopolamine Butyl Bromide API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Scopolamine Butyl Bromide API Production Value by Region (2020-2031)
3.2.1 Global Scopolamine Butyl Bromide API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Scopolamine Butyl Bromide API by Region (2026-2031)
3.3 Global Scopolamine Butyl Bromide API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Scopolamine Butyl Bromide API Production Volume by Region (2020-2031)
3.4.1 Global Scopolamine Butyl Bromide API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Scopolamine Butyl Bromide API by Region (2026-2031)
3.5 Global Scopolamine Butyl Bromide API Market Price Analysis by Region (2020-2025)
3.6 Global Scopolamine Butyl Bromide API Production and Value, Year-over-Year Growth
3.6.1 North America Scopolamine Butyl Bromide API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Scopolamine Butyl Bromide API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Scopolamine Butyl Bromide API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Scopolamine Butyl Bromide API Production Value Estimates and Forecasts (2020-2031)
4 Scopolamine Butyl Bromide API Consumption by Region
4.1 Global Scopolamine Butyl Bromide API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Scopolamine Butyl Bromide API Consumption by Region (2020-2031)
4.2.1 Global Scopolamine Butyl Bromide API Consumption by Region (2020-2025)
4.2.2 Global Scopolamine Butyl Bromide API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Scopolamine Butyl Bromide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Scopolamine Butyl Bromide API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Scopolamine Butyl Bromide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Scopolamine Butyl Bromide API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Scopolamine Butyl Bromide API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Scopolamine Butyl Bromide API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Scopolamine Butyl Bromide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Scopolamine Butyl Bromide API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Scopolamine Butyl Bromide API Production by Type (2020-2031)
5.1.1 Global Scopolamine Butyl Bromide API Production by Type (2020-2025)
5.1.2 Global Scopolamine Butyl Bromide API Production by Type (2026-2031)
5.1.3 Global Scopolamine Butyl Bromide API Production Market Share by Type (2020-2031)
5.2 Global Scopolamine Butyl Bromide API Production Value by Type (2020-2031)
5.2.1 Global Scopolamine Butyl Bromide API Production Value by Type (2020-2025)
5.2.2 Global Scopolamine Butyl Bromide API Production Value by Type (2026-2031)
5.2.3 Global Scopolamine Butyl Bromide API Production Value Market Share by Type (2020-2031)
5.3 Global Scopolamine Butyl Bromide API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Scopolamine Butyl Bromide API Production by Application (2020-2031)
6.1.1 Global Scopolamine Butyl Bromide API Production by Application (2020-2025)
6.1.2 Global Scopolamine Butyl Bromide API Production by Application (2026-2031)
6.1.3 Global Scopolamine Butyl Bromide API Production Market Share by Application (2020-2031)
6.2 Global Scopolamine Butyl Bromide API Production Value by Application (2020-2031)
6.2.1 Global Scopolamine Butyl Bromide API Production Value by Application (2020-2025)
6.2.2 Global Scopolamine Butyl Bromide API Production Value by Application (2026-2031)
6.2.3 Global Scopolamine Butyl Bromide API Production Value Market Share by Application (2020-2031)
6.3 Global Scopolamine Butyl Bromide API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Scopolamine Butyl Bromide API Company Information
7.1.2 Boehringer Ingelheim Scopolamine Butyl Bromide API Product Portfolio
7.1.3 Boehringer Ingelheim Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Boehringer Ingelheim Main Business and Markets Served
7.1.5 Boehringer Ingelheim Recent Developments/Updates
7.2 Alkaloids Corporation
7.2.1 Alkaloids Corporation Scopolamine Butyl Bromide API Company Information
7.2.2 Alkaloids Corporation Scopolamine Butyl Bromide API Product Portfolio
7.2.3 Alkaloids Corporation Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Alkaloids Corporation Main Business and Markets Served
7.2.5 Alkaloids Corporation Recent Developments/Updates
7.3 Alchem International Private Ltd
7.3.1 Alchem International Private Ltd Scopolamine Butyl Bromide API Company Information
7.3.2 Alchem International Private Ltd Scopolamine Butyl Bromide API Product Portfolio
7.3.3 Alchem International Private Ltd Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Alchem International Private Ltd Main Business and Markets Served
7.3.5 Alchem International Private Ltd Recent Developments/Updates
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Scopolamine Butyl Bromide API Company Information
7.4.2 Abbott Laboratories Scopolamine Butyl Bromide API Product Portfolio
7.4.3 Abbott Laboratories Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Abbott Laboratories Main Business and Markets Served
7.4.5 Abbott Laboratories Recent Developments/Updates
7.5 Sanofi
7.5.1 Sanofi Scopolamine Butyl Bromide API Company Information
7.5.2 Sanofi Scopolamine Butyl Bromide API Product Portfolio
7.5.3 Sanofi Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Sanofi Main Business and Markets Served
7.5.5 Sanofi Recent Developments/Updates
7.6 LGM Pharma
7.6.1 LGM Pharma Scopolamine Butyl Bromide API Company Information
7.6.2 LGM Pharma Scopolamine Butyl Bromide API Product Portfolio
7.6.3 LGM Pharma Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 LGM Pharma Main Business and Markets Served
7.6.5 LGM Pharma Recent Developments/Updates
7.7 Transo-Pharm Handels GmbH
7.7.1 Transo-Pharm Handels GmbH Scopolamine Butyl Bromide API Company Information
7.7.2 Transo-Pharm Handels GmbH Scopolamine Butyl Bromide API Product Portfolio
7.7.3 Transo-Pharm Handels GmbH Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Transo-Pharm Handels GmbH Main Business and Markets Served
7.7.5 Transo-Pharm Handels GmbH Recent Developments/Updates
7.8 Aspen API
7.8.1 Aspen API Scopolamine Butyl Bromide API Company Information
7.8.2 Aspen API Scopolamine Butyl Bromide API Product Portfolio
7.8.3 Aspen API Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Aspen API Main Business and Markets Served
7.8.5 Aspen API Recent Developments/Updates
7.9 Jai Radhe Sales
7.9.1 Jai Radhe Sales Scopolamine Butyl Bromide API Company Information
7.9.2 Jai Radhe Sales Scopolamine Butyl Bromide API Product Portfolio
7.9.3 Jai Radhe Sales Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Jai Radhe Sales Main Business and Markets Served
7.9.5 Jai Radhe Sales Recent Developments/Updates
7.10 Tenatra Chemie
7.10.1 Tenatra Chemie Scopolamine Butyl Bromide API Company Information
7.10.2 Tenatra Chemie Scopolamine Butyl Bromide API Product Portfolio
7.10.3 Tenatra Chemie Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Tenatra Chemie Main Business and Markets Served
7.10.5 Tenatra Chemie Recent Developments/Updates
7.11 Capital Farma
7.11.1 Capital Farma Scopolamine Butyl Bromide API Company Information
7.11.2 Capital Farma Scopolamine Butyl Bromide API Product Portfolio
7.11.3 Capital Farma Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Capital Farma Main Business and Markets Served
7.11.5 Capital Farma Recent Developments/Updates
7.12 Bazayan & Co
7.12.1 Bazayan & Co Scopolamine Butyl Bromide API Company Information
7.12.2 Bazayan & Co Scopolamine Butyl Bromide API Product Portfolio
7.12.3 Bazayan & Co Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Bazayan & Co Main Business and Markets Served
7.12.5 Bazayan & Co Recent Developments/Updates
7.13 Biotechnica DWC
7.13.1 Biotechnica DWC Scopolamine Butyl Bromide API Company Information
7.13.2 Biotechnica DWC Scopolamine Butyl Bromide API Product Portfolio
7.13.3 Biotechnica DWC Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Biotechnica DWC Main Business and Markets Served
7.13.5 Biotechnica DWC Recent Developments/Updates
7.14 Linnea
7.14.1 Linnea Scopolamine Butyl Bromide API Company Information
7.14.2 Linnea Scopolamine Butyl Bromide API Product Portfolio
7.14.3 Linnea Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Linnea Main Business and Markets Served
7.14.5 Linnea Recent Developments/Updates
7.15 Jiangsu Hengrui Medicine
7.15.1 Jiangsu Hengrui Medicine Scopolamine Butyl Bromide API Company Information
7.15.2 Jiangsu Hengrui Medicine Scopolamine Butyl Bromide API Product Portfolio
7.15.3 Jiangsu Hengrui Medicine Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Jiangsu Hengrui Medicine Main Business and Markets Served
7.15.5 Jiangsu Hengrui Medicine Recent Developments/Updates
7.16 Remedy Labs
7.16.1 Remedy Labs Scopolamine Butyl Bromide API Company Information
7.16.2 Remedy Labs Scopolamine Butyl Bromide API Product Portfolio
7.16.3 Remedy Labs Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Remedy Labs Main Business and Markets Served
7.16.5 Remedy Labs Recent Developments/Updates
7.17 Rumit Group of Companies
7.17.1 Rumit Group of Companies Scopolamine Butyl Bromide API Company Information
7.17.2 Rumit Group of Companies Scopolamine Butyl Bromide API Product Portfolio
7.17.3 Rumit Group of Companies Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Rumit Group of Companies Main Business and Markets Served
7.17.5 Rumit Group of Companies Recent Developments/Updates
7.18 Vital Laboratories Private Limited
7.18.1 Vital Laboratories Private Limited Scopolamine Butyl Bromide API Company Information
7.18.2 Vital Laboratories Private Limited Scopolamine Butyl Bromide API Product Portfolio
7.18.3 Vital Laboratories Private Limited Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.18.4 Vital Laboratories Private Limited Main Business and Markets Served
7.18.5 Vital Laboratories Private Limited Recent Developments/Updates
7.19 Zhejiang Ausun Pharmaceutical
7.19.1 Zhejiang Ausun Pharmaceutical Scopolamine Butyl Bromide API Company Information
7.19.2 Zhejiang Ausun Pharmaceutical Scopolamine Butyl Bromide API Product Portfolio
7.19.3 Zhejiang Ausun Pharmaceutical Scopolamine Butyl Bromide API Production, Value, Price and Gross Margin (2020-2025)
7.19.4 Zhejiang Ausun Pharmaceutical Main Business and Markets Served
7.19.5 Zhejiang Ausun Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Scopolamine Butyl Bromide API Industry Chain Analysis
8.2 Scopolamine Butyl Bromide API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Scopolamine Butyl Bromide API Production Mode & Process Analysis
8.4 Scopolamine Butyl Bromide API Sales and Marketing
8.4.1 Scopolamine Butyl Bromide API Sales Channels
8.4.2 Scopolamine Butyl Bromide API Distributors
8.5 Scopolamine Butyl Bromide API Customer Analysis
9 Scopolamine Butyl Bromide API Market Dynamics
9.1 Scopolamine Butyl Bromide API Industry Trends
9.2 Scopolamine Butyl Bromide API Market Drivers
9.3 Scopolamine Butyl Bromide API Market Challenges
9.4 Scopolamine Butyl Bromide API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Scopolamine Butyl Bromide API market is projected to grow from US$ 1320 million in 2025 to US$ 1776 million by 2032, at a CAGR of 4.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 171
USD 4900.00
(Single User License)
The global Scopolamine Butyl Bromide API market size was US$ 1320 million in 2025 and is forecast to reach a readjusted size of US$ 1776 million by 2032 with a CAGR of 4.4% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 102
USD 4250.00
(Single User License)
The global Scopolamine Butyl Bromide API market was valued at US$ 1320 million in 2025 and is anticipated to reach US$ 1776 million by 2032, at a CAGR of 4.4% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 148
USD 2900.00
(Single User License)
The global market for Scopolamine Butyl Bromide API was estimated to be worth US$ 1320 million in 2025 and is projected to reach US$ 1776 million, growing at a CAGR of 4.4% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 143
USD 3950.00
(Single User License)
The global market for Scopolamine Butyl Bromide API was estimated to be worth US$ 1265 million in 2024 and is forecast to a readjusted size of US$ 1708 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-02-22
Pages: 146
USD 3950.00
(Single User License)
Valued at US$ 1320 million in 2024, the global Scopolamine Butyl Bromide API market is forecast to reach US$ 1708 million by 2030, at a CAGR of 4.4% during the forecast period.
Published Date: 2025-02-22
Pages: 179
USD 4900.00
(Single User License)
The global Scopolamine Butyl Bromide API market size was US$ 1265 million in 2024 and is forecast to a readjusted size of US$ 1708 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-02-22
Pages: 103
USD 4250.00
(Single User License)
The global Scopolamine Butyl Bromide API market is projected to grow from US$ 1320 million in 2025 to US$ 1776 million by 2032, at a CAGR of 4.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 171
The global Scopolamine Butyl Bromide API market size was US$ 1320 million in 2025 and is forecast to reach a readjusted size of US$ 1776 million by 2032 with a CAGR of 4.4% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 102
The global Scopolamine Butyl Bromide API market was valued at US$ 1320 million in 2025 and is anticipated to reach US$ 1776 million by 2032, at a CAGR of 4.4% from 2026 to 2032.
Published: 2026-03-11
Pages: 148
The global market for Scopolamine Butyl Bromide API was estimated to be worth US$ 1320 million in 2025 and is projected to reach US$ 1776 million, growing at a CAGR of 4.4% from 2026 to 2032.
Published: 2026-03-08
Pages: 143
The global market for Scopolamine Butyl Bromide API was estimated to be worth US$ 1265 million in 2024 and is forecast to a readjusted size of US$ 1708 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-02-22
Pages: 146
Valued at US$ 1320 million in 2024, the global Scopolamine Butyl Bromide API market is forecast to reach US$ 1708 million by 2030, at a CAGR of 4.4% during the forecast period.
Published: 2025-02-22
Pages: 179
The global Scopolamine Butyl Bromide API market size was US$ 1265 million in 2024 and is forecast to a readjusted size of US$ 1708 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-02-22
Pages: 103
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now